retatrutide tachycardia 🔬 — why cardiology and the gym are paying attention For years, peptides lived in bro science or medicine — rarely both. TRIUMPH-4 (Phase 3) changed that. Topline signals: • ~30% Inotropic effects of retatrutide in

It represents a new generation of investigational peptides designed to simulate natural hormonal responses involved in glucose metabolism, appetite suppression, and energy balance

There are now three pathways for cardiometabolic indications: Type 2 diabetes

The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss

Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is FDA-approved for chronic weight management in adults with obesity or overweight

We observed a clear dose-response relationship in our analysis, with the risk of nAMD increasing as the duration of GLP-1 receptor agonist exposure increased, Muni explained

Can I reduce the dose